Metyrapone

Metyrapone
Clinical data
Trade names	Metopirone
AHFS/Drugs.com	Consumer Drug Information
Pregnancy; category	C US;
Routes of; administration	By mouth
ATC code	V04CD01 (WHO) ;
Pharmacokinetic data
Elimination half-life	1.9 ± 0.7 hours
Identifiers
	IUPAC name 2-methyl-1,2-di(pyridin-3-yl)propan-1-one;
CAS Number	54-36-4 ;
PubChem CID	4174;
IUPHAR/BPS	5224;
DrugBank	DB01011 ;
ChemSpider	4030 ;
UNII	ZS9KD92H6V;
KEGG	D00410 ;
ChEBI	CHEBI:44241 ;
ChEMBL	ChEMBL934 ;
CompTox Dashboard (EPA)	DTXSID1023314 ;
ECHA InfoCard	100.000.188
Chemical and physical data
Formula	C14H14N2O
Molar mass	226.279 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(c1cccnc1)C(c2cccnc2)(C)C;
	InChI InChI=1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3 ; Key:FJLBFSROUSIWMA-UHFFFAOYSA-N ;
	(verify)

Metyrapone, sold under the brand name Metopirone, is a medication which is used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome (hypercortisolism). It is part of the steroidogenesis inhibitor class of drugs.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.